Sign Up for Email Alerts
Kineta Inc.
Kineta Inc.
Kineta Inc.
Close
  • About Us
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean
  • About Us
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean

[be_recent_posts_author_no_link title=”Latest News from Kineta” category_id=”4,3″ num_posts=”6″ post_offset=”0″ num_words_limit=”0″ show_date_author=”1″ show_more_link=”0″ more_link_text=”Read more” show_thumbs=”0″ remove_thumb_frame=”0″ thumb_frame_shadow=”0″ default_thumb=”0″ post_thumb_width=”100″ post_thumb_height=”80″]

Recent Kineta News

  • Interim results of the ongoing phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors
  • Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
  • Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
  • KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported
  • VISTA a potential new Immuno-oncology therapeutic target to treat human Acute Myeloid Leukemia
Post placeholder image
May 13, 2020 in Biotech Industry News

Seattle Biotech CEO Keeps A Watchful Eye on the Market for Potential IPO

Kineta Inc 8 Like Post Comments Off on Seattle Biotech CEO Keeps A Watchful Eye on the Market for Potential IPO
Read More
Post placeholder image
March 25, 2020 in Kineta Press Release

Kineta to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference

Kineta Inc 7 Like Post Comments Off on Kineta to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference

Kineta to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference Seattle, WA -- (March 24, 2020) Kineta, Inc., a clinical stage biotechnology company focused on the development of ...

Read More
Post placeholder image
February 27, 2020 in Kineta Press Release

Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference

Kineta Inc 5 Like Post Comments Off on Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference

Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference Seattle, WA -- (February 26, 2020) Kineta, Inc., a clinical stage biotechnology company focused on the develo ...

Read More
Post placeholder image
February 5, 2020 in Kineta Press Release

Kineta Invited to Participate at the BIO CEO & Investor Conference

Kineta Inc 5 Like Post Comments Off on Kineta Invited to Participate at the BIO CEO & Investor Conference

Kineta Invited to Participate at the BIO CEO & Investor Conference Seattle, WA -- (February 5, 2020) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immun ...

Read More
Post placeholder image
November 26, 2019 in Kineta Press Release

Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference

Kineta Inc 5 Like Post Comments Off on Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference

Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference Seattle, WA -- (November 26, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development o ...

Read More
Post placeholder image
October 7, 2019 in Kineta Press Release

Kineta Invited to Participate at October 2019 Investor Conferences

Kineta Inc 3 Like Post Comments Off on Kineta Invited to Participate at October 2019 Investor Conferences

Kineta Invited to Participate at October 2019 Investor Conferences Seattle, WA -- (October 7, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunother ...

Read More
Post placeholder image
September 17, 2019 in Biotech Industry News

After a run of CTLA-4 combo failures, scientists spotlight a way to make it work — in select patients

Kineta Inc 2 Like Post Comments Off on After a run of CTLA-4 combo failures, scientists spotlight a way to make it work — in select patients
Read More
Post placeholder image
August 29, 2019 in Kineta Press Release

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference

Kineta Inc 5 Like Post Comments Off on Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference Seattle, WA -- (August 28, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the deve ...

Read More
Post placeholder image
August 21, 2019 in Biotech Industry News

Kineta Acquires Translation Fund Award $1.8 Million from Welcome Trusts

Kineta Inc 2 Like Post Comments Off on Kineta Acquires Translation Fund Award $1.8 Million from Welcome Trusts
Read More
Post placeholder image
August 12, 2019 in Kineta Press Release

Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference

Kineta Inc 3 Like Post Comments Off on Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference

Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference Seattle, WA -- (August 12, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development ...

Read More
Prev12345…9Next

219 Terry Ave. N. Suite 300. Seattle, WA 98109

Sign Up for Email Alerts

219 Terry Ave. N. Suite 300. Seattle, WA 98109

  • About Us
  • pipeline
  • partnerships
  • investors
  • contact
Sign Up for Email Alerts

© 2024 Kineta Inc. Privacy Policy Terms of Use

English
English
Korean